Hims & Hers Health (XSWX:HIMS) Other Operating Expense: CHF319.91 Mil (TTM As of Mar. 2026)


XSWX:HIMS Hims & Hers Health Inc XSWX:HIMS
81 GF Score
Price CHF29.90
GF Value CHF32.30
! 3 Warning Signs
View Full Analysis

What is Hims & Hers Health Other Operating Expense?

Hims & Hers Health XSWX:HIMS 81 Other Operating Expense is CHF319.91 Mil as of Mar. 2026. GuruFocus rates XSWX:HIMS with a GF Score™ of 81/100 and a GF Value™ of CHF32.30. The stock has 3 warning signs investors should review.

Hims & Hers Health's Other Operating Expense for the three months ended in Mar. 2026 was CHF96.50 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was CHF319.91 Mil.

Hims & Hers Health's quarterly Other Operating Expense increased from Sep. 2025 (CHF76.85 Mil) to Dec. 2025 (CHF80.07 Mil) and increased from Dec. 2025 (CHF80.07 Mil) to Mar. 2026 (CHF96.50 Mil).

Hims & Hers Health's annual Other Operating Expense increased from Dec. 2023 (CHF119.86 Mil) to Dec. 2024 (CHF185.80 Mil) and increased from Dec. 2024 (CHF185.80 Mil) to Dec. 2025 (CHF286.44 Mil).

Hims & Hers Health Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Hims & Hers Health's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hims & Hers Health Other Operating Expense Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial 47.59 77.40 119.86 185.80 286.44

Hims & Hers Health Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 63.03 66.49 76.85 80.07 96.50
XSWX:HIMS
81GF Score
Hims & Hers Health Inc XSWX:HIMS
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Hims & Hers Health Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF319.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of CHF319.91 Mil mean?
Hims & Hers Health (XSWX:HIMS) has a Other Operating Expense of CHF319.91 Mil as of Mar. 2026. Other operating expenses that a company records on its income statement. View historical data on Hims & Hers Health and its competitors.
Is Hims & Hers Health's Other Operating Expense too high?
Hims & Hers Health's current Other Operating Expense is CHF319.91 Mil. Overall, Hims & Hers Health has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's Other Operating Expense compare to ?
Hims & Hers Health's Other Operating Expense of CHF319.91 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Drug Manufacturers company?
A good Other Operating Expense depends on the Drug Manufacturers industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Hims & Hers Health and its competitors. Hims & Hers Health's current Other Operating Expense is CHF319.91 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Hims & Hers Health (XSWX:HIMS) has a current Other Operating Expense of CHF319.91 Mil. The stock's GF Value™ is CHF32.30, compared to a current price of CHF29.90 — trading 7.4% below its estimated fair value. The current Other Operating Expense is CHF319.91 Mil. Hims & Hers Health's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Hims & Hers Health (XSWX:HIMS), the current Other Operating Expense is CHF319.91 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Hims & Hers Health (XSWX:HIMS) Overvalued in 2026?

Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued. The current stock price of CHF29.90 is trading 7.4% below its estimated GF Value™ of CHF32.30.

Key valuation signals for XSWX:HIMS:

  • Other Operating Expense: CHF319.91 Mil
  • GF Value™: CHF32.30 vs. price of CHF29.90 (7.4% below fair value)
  • GF Score™: 81/100 with 3 warning signs

No single metric tells the full story. See the XSWX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Hims & Hers Health Business Description

Comparable Companies
Address 2269 Chestnut Street, No. 523, San Francisco, CA, USA, 94123
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
81GF Score

Get the complete analysis for XSWX:HIMS

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF29.90
Price
CHF32.30
GF Value